trusopt dorzolamide 20mg/ml (as hydrochloride) eye drops bottle
mundipharma pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium citrate dihydrate; benzalkonium chloride; hyetellose; water for injections; sodium hydroxide - trusopt eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open- angle glaucoma.
trusopt- dorzolamide hydrochloride solution
merck sharp & dohme llc - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml - trusopt® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. trusopt is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.1)] . risk summary there are no adequate and well-controlled studies in pregnant women with trusopt. dorzolamide caused fetal vertebral malformations when administered orally to rabbits at 2.5 mg/kg/day (37 times the clinical exposure). dorzolamide administered during the period of organogenesis was not teratogenic in rabbits dosed up to 1 mg/kg/day (15 times the clinical exposure). dorzolamide hydrochloride administered orally to rats during late gestation and lactation caused growth delays in offspring at 7.5 mg/kg/day (52 times the clinical exposure). growth was not delayed at 1 mg/kg/day (8.0 times the clinical exposure). the background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general populati
trusopt
mundipharma new zealand ltd - dorzolamide hydrochloride 2.226%{relative} equivalent to dorzolamide base 2% - eye drops, solution - 2 % - active: dorzolamide hydrochloride 2.226%{relative} equivalent to dorzolamide base 2% excipient: benzalkonium chloride hyetellose mannitol sodium citrate dihydrate sodium hydroxide water for injection - trusopt ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma and other secondary open-angle glaucomas · in the short-term treatment of paediatric glaucomas as adjunctive therapy to beta-blockers and for monotherapy when other treatments have proved ineffective or are unsuitable.
trusopt
rafa laboratories ltd - dorzolamide as hydrochloride - ophthalmic solution - dorzolamide as hydrochloride 20 mg/ml - dorzolamide - dorzolamide - for the treatment of eleveated intraocular pressure in patients with ocular hypertension, open-angle glaucoma and in some patients secondary glaucoma.
trusopt 20mg/ml eye drops
santen uk ltd - dorzolamide hydrochloride - eye drops - 20mg/1ml
trusopt
merck sharp & dohme australia pty ltd - dorzolamide hydrochloride -
trusopt 20mg/ml eye drops, solution
merck sharp & dohme limited hertford road, hoddesdon, hertfordshire en11 9bu, united kingdom - dorzolamide - eye drops, solution - dorzolamide 20 mg/ml - ophthalmologicals
trusopt 20 mg/ml eye drops, solution
santen oy - dorzolamide hydrochloride - eye drops, solution - 20 milligram(s)/millilitre - dorzolamide - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, dorzolamide - it is indicated: as adjunctive therapy to beta-blockers, as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated, in the treatment of elevated intra-ocular pressure in: ocular hypertension, open-angle glaucoma, pseudoexfoliative glaucoma.
trusopt preservative-free 20 mg/ml eye drops, solution in single-dose container
santen oy - dorzolamide - eye drops, solution in single-dose container - 20 milligram(s)/millilitre - carbonic anhydrase inhibitors; dorzolamide - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors, dorzolamide - it l is indicated: as adjunctive therapy to beta-blockers; as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated; in the treatment of elevated intra-ocular pressure in: ocular hypertension; open-angle glaucoma; pseudoexfoliative glaucoma.
trusopt 20mg/ml eye drops 0.2ml unit dose preservative free
santen uk ltd - dorzolamide hydrochloride - eye drops - 20mg/1ml